ZG16B inhibitor

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

No biomarker	Pancreatic Adenocarcinoma	No biomarker	Pancreatic Adenocarcinoma	PBP1510 Sensitive: B - Late Trials PBP1510 Sensitive : B	PBP1510 Sensitive: B - Late Trials PBP1510 Sensitive : B
ZG16B positive	Prostate Cancer	ZG16B positive	Prostate Cancer	PBP1510 Sensitive: D – Preclinical PBP1510 Sensitive : D	PBP1510 Sensitive: D – Preclinical PBP1510 Sensitive : D
ZG16B expression	Ovarian Cancer	ZG16B expression	Ovarian Cancer	PBP1510 Sensitive: D – Preclinical PBP1510 Sensitive : D	PBP1510 Sensitive: D – Preclinical PBP1510 Sensitive : D

Associations(3)